Related content

Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials

By Ormsby Eleanor L.   Pavlik Edward J.   McGahan John P.  

Diagnostics, Vol. 7, Iss. 2, 2017-04 ,pp. : 25-25

MDPI

Access to resources Recommend Favorite

Ten Important Considerations for Ovarian Cancer Screening

By Pavlik Edward J.  

Diagnostics, Vol. 7, Iss. 2, 2017-04 ,pp. : 22-22

MDPI

Access to resources Recommend Favorite

Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population

By Froyman Wouter   Wynants Laure   Landolfo Chiara   Bourne Tom   Valentin Lil   Testa Antonia   Sladkevicius Povilas   Franchi Dorella   Fischerova Daniela   Savelli Luca   Van Calster Ben   Timmerman Dirk  

Diagnostics, Vol. 7, Iss. 2, 2017-06 ,pp. : 32-32

MDPI

Access to resources Recommend Favorite

Establishing and Sustaining a Prospective Screening Program for Breast Cancer-Related Lymphedema at the Massachusetts General Hospital: Lessons Learned

By Brunelle Cheryl   Skolny Melissa   Ferguson Chantal   Swaroop Meyha   O’Toole Jean   Taghian Alphonse G.  

Journal of Personalized Medicine, Vol. 5, Iss. 2, 2015-05 ,pp. : 153-164

MDPI

Access to resources Recommend Favorite

Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome

By Trepanier Angela M.   Supplee Laura   Blakely Lindsey   McLosky Jenna   Duquette Debra  

Healthcare, Vol. 4, Iss. 1, 2016-03 ,pp. : 19-19

MDPI

Access to resources Recommend Favorite